Neopharm Trade EAD (Неофарм Трейд ЕАД) is based in Bulgaria, with the head office in Sofia. The enterprise currently operates in the General Line Grocery Merchant Wholesalers sector. It was first established on October 28, 2026. It currently has a total number of 72 (2024) employees. From the latest financial highlights, Neopharm Trade EAD (Неофарм Трейд ЕАД) reported a net sales revenue increase of 127.11% in 2024. Over the same period, its total assets decreased by 27.34%. Neopharm Trade EAD (Неофарм Трейд ЕАД)’s net profit margin decreased by 7.45% in 2024.

Headquarters
Bul. Cherni Vrah 29
Sofia; Sofia - city; Postal Code: 1421

Contact Details: Purchase the Neopharm Trade EAD (Неофарм Трейд ЕАД) report to view the information.

Basic Information

Total Employees:

Purchase the Neopharm Trade EAD (Неофарм Трейд ЕАД) report to view the information.

Registered Capital:

Purchase the Neopharm Trade EAD (Неофарм Трейд ЕАД) report to view the information.

Financial Auditors:

Purchase the Neopharm Trade EAD (Неофарм Трейд ЕАД) report to view the information.

Incorporation Date:

October 28, 2026

Key Executives

Purchase this report to view the information.

Executive Director and Member of the Board of Directors

Purchase this report to view the information.

Member of the Board of Directors

Purchase this report to view the information.

Member of the Board of Directors

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Neopharm Trade EAD (Неофарм Трейд ЕАД) report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.

Net sales revenue

127.11%▲

Total Operating Revenue

127.15%▲

Operating Profit

-47.64%▼

EBITDA

-44.43%▼

Net Profit/Loss for the Period

-49.8%▼

Total Assets

-27.34%▼

Total Equity

48.57%▲

Operating Profit Margin

-8.19%▼

Net Profit Margin

-7.45%▼

Return on Equity (ROE)

-64.05%▼

Quick Ratio

1.32%▲

Cash Ratio

1.4%▲

Neopharm Trade EAD (Неофарм Трейд ЕАД) (Bulgaria)

Similar companies